Christopher Pieczonka
- Urology top 5%
-
- Prostate Cancer Treatment and Research 57
- Prostate Cancer Diagnosis and Treatment 14
- Radiation top 10%
-
- Hormonal and reproductive studies 6
- Rheumatology top 10%
-
- Radiopharmaceutical Chemistry and Applications 23
-
- Cancer Immunotherapy and Biomarkers 18
- Cancer Treatment and Pharmacology 6
- Bone health and treatments 4
-
- Cancer, Lipids, and Metabolism 7
- Co-authors
- Neal D. ShoreLawrence I. KarshNoel A. ArmenakasDuncan J. SummertonCharles L. SecrestAllen F. MoreyPaige WhiteDavid A. Hochberg
- Journals
- Journal of Clinical Oncology (26 papers)The Journal of Urology (9 papers)Annals of Oncology (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Christopher Pieczonka
58 papers receiving 663 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Urology 122
- Pulmonary and Respiratory Medicine 433
- Radiation 63
- Endocrinology, Diabetes and Metabolism 98
- Rheumatology 85
Countries citing papers authored by Christopher Pieczonka
This map shows the geographic impact of Christopher Pieczonka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pieczonka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pieczonka more than expected).
Fields of papers citing papers by Christopher Pieczonka
This network shows the impact of papers produced by Christopher Pieczonka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pieczonka. The network helps show where Christopher Pieczonka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher Pieczonka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancerbreakdown → | 2023 | 114 |
| 8 | 2023 | 8 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 28 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 50 | |
| 16 | 2020 | 6 | |
| 17 | 2017 | 82 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 2 | |
| 20 | 2014 | 8 |
About Christopher Pieczonka
Christopher Pieczonka is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Statistics and Probability, having authored 69 papers that have together received 679 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (57 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Cancer Immunotherapy and Biomarkers (18 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Cancer, Lipids, and Metabolism (7 papers), Cancer Treatment and Pharmacology (6 papers), Hormonal and reproductive studies (6 papers) and Bone health and treatments (4 papers). The work is most often cited by research in Urology (122 citations), Pulmonary and Respiratory Medicine (433 citations), Radiation (63 citations), Endocrinology, Diabetes and Metabolism (98 citations) and Rheumatology (85 citations). Christopher Pieczonka has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Neal D. Shore, Lawrence I. Karsh, Noel A. Armenakas, Duncan J. Summerton, Charles L. Secrest, Allen F. Morey, Paige White, David A. Hochberg, Jack W. McAninch and K. Miller. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Annals of Oncology, Urologic Oncology Seminars and Original Investigations and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.